Central Texas-based St. David?s HealthCare has announced the establishment of Texas Institute for Robotic Surgery at St. David?s North Austin Medical Center, which has recruited urologist Randy Fagin, MD, as the institute?s chief administrative officer.
Central Texas-based St. David’s HealthCare has announced the establishment of Texas Institute for Robotic Surgery at St. David’s North Austin Medical Center, which has recruited urologist Randy Fagin, MD, as the institute’s chief administrative officer.
Texas Institute for Robotic Surgery will feature the Robotic Institute University, what it says is the nation’s first educational epicenter teaching best practices for hospital and surgical teams involved in robot-assisted surgery.
In his new role, Dr. Fagin will assist in the recruitment of other internationally known robot-assisted surgeons in a variety of specialties, develop and implement programs to elevate the consistency and quality of patient care, and develop educational training programs for physicians and hospital teams.
Dr. Fagin has served as the senior medical adviser for Intuitive Surgical, Inc. for the past 2 years. He has performed more than 2,100 robotic-assisted surgeries, as well as trained surgeons from around the world. For the past 6 years, Dr. Fagin has performed surgery live at the AUA annual meeting.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.